Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Alzohalli, Opada M.D.
WARNING LETTER
•Alzohalli, Opada M.D.•August 14, 2013

Alzohalli, Opada M.D. – FDA Warning Letter, Aug 14, 2013

Record Details

This FDA Warning Letter, dated July 17, 2014, addresses Dr. Opada Alzohaili regarding objectionable conditions observed during an FDA inspection from July 18 to August 14, 2013. The inspection reviewed Dr. Alzohaili's conduct of seven clinical investigations of the investigational drug Albiglutide for GlaxoSmithKline, as part of the Bioresearch Monitoring Program.

The letter identifies three main violations:

1. **Failure to protect the rights, safety, and welfare of subjects (21 CFR 312.60):** * **Delayed hyperglycemia rescue:** Subject 001 (Protocol GLP112756) experienced a three-week delay in receiving rescue medication despite meeting criteria. Subject 004 (Protocol GLP108486) had a three-week delay in rescue medication. Dr. Alzohaili's responses regarding subject non-compliance and misunderstanding of the protocol were deemed inadequate due to lack of documentation and insufficient corrective action details. * **Incorrect investigational drug dispensing:** Subject 005 (Protocol GLP112756) received a pen intended for Subject 006. Subject 007 (Protocol GLP112757) received a pen assigned to Subject 001 from a different protocol. The corrective

Company
Alzohalli, Opada M.D.
Inspection date
August 14, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Constance Cullity
  • Sean Y. Kassim (Deputy Office Director)
View Company Profile

ID · 384ec595-656d-44aa-bc9b-fe4d89cb82c2

Violation Codes2
21 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alzohalli, Opada M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.